Human seminal fluid as a source of prostate cancer-specific microRNA biomarkers

Endocrine-Related Cancer

Volumn 21, Issue 4, 2014, Pages

  Selth, Luke A ^a   Roberts, Matthew J ^b,c   Chow, Clement W K ^b,d   Marshall, Villis R ^a   Doi, Suhail A R ^e,f   Vincent, Andrew D ^a   Butler, Lisa M ^a   Lavin, Martin F ^b,d   Tilley, Wayne D ^a   Gardiner, Robert A ^b,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 125B; MICRORNA 141; MICRORNA 153; MICRORNA 16; MICRORNA 200; MICRORNA 200B; MICRORNA 200C; MICRORNA 203; MICRORNA 215; MICRORNA 30A; MICRORNA 34C; MICRORNA 363 3P; MICRORNA 375; MICRORNA 449A; MICRORNA 96; MICRORNA 99A; PROSTATE SPECIFIC ANTIGEN; SMALL CYTOPLASMIC RNA; SMALL NUCLEAR RNA; SMALL NUCLEOLAR RNA; TRANSFER RNA; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AREA UNDER THE CURVE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLEASON SCORE; HUMAN; LETTER; MALE; PROSTATE BIOPSY; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEMINAL PLASMA; AGED; METABOLISM; MIDDLE AGED; PROSTATIC NEOPLASMS; REPRODUCIBILITY; SPERM;

AGED; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SEMEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84905993788     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-14-0234     Document Type: Letter

References (10)

1. Dall'Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, Freedland SJ, Klotz LH, Parker C & Soloway MS 2012 Active surveillance for prostate cancer: a systematic review of the literature. European Urology 62 976-983. (doi:10.1016/j.eururo.2012.05.072)
2. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ et al. 1998 Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. Journal of the American Medical Association 280 969-974. (doi:10.1001/jama.280.11.969)
3. Gardiner RA, Burger M, Clements JA & Lavin MF 2003 Realizing the potential of ejaculate/seminal fluid in detecting and predicting natural history. Methods in Molecular Medicine 81 199-217. (doi:10.1385/1-59259-372-0: 199)
4. Haas GP, Delongchamps NB, Jones RF, Chandan V, Serio AM, Vickers AJ, Jumbelic M, Threatte G, Korets R, Lilja H et al. 2007 Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. Journal of the National Cancer Institute 99 1484-1489. (doi:10.1093/jnci/djm153)
5. Roberts MJ, Schirra HJ, Lavin MF & Gardiner RA 2011 Metabolomics: a novel approach to early and noninvasive prostate cancer detection. Korean Journal of Urology 52 79-89. (doi:10.4111/kju.2011.52.2.79)
6. Roobol MJ & Carlsson SV 2013 Risk stratification in prostate cancer screening. Nature Reviews. Urology 10 38-48. (doi:10.1038/nrurol.2012.225)
7. Sapre N & Selth LA 2013 Circulating microRNAs as biomarkers of prostate cancer: the state of play. Prostate Cancer 2013 539680. (doi:10.1155/2013/539680)
8. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M et al. 2009 Screening and prostate-cancer mortality in a randomized European study. New England Journal of Medicine 360 1320-1328. (doi:10.1056/NEJMoa0810084)
9. Selth LA, Tilley WD & Butler LM 2012 Circulating microRNAs: macroutility as markers of prostate cancer? Endocrine-Related Cancer 19 R99-R113. (doi:10.1530/ERC-12-0010)
10. Tomlins SA, Aubin SM, Siddiqui J, Lonigro RJ, Sefton-Miller L, Miick S, Williamsen S, Hodge P, Meinke J, Blase A et al. 2011 Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Science Translational Medicine 3 94ra72. (doi:10.1126/scitranslmed.3001970)